Cytokinetics, Incorporated Stock Agreements
15 Contracts & Agreements
- Cytokinetics, Incorporated Amended and Restated 2015 Employee Stock Purchase Plan (Filed With SEC on May 17, 2024)
- Common Stock Purchase Agreement, dated December 20, 2021, by and between the Company and RTW Venture Fund Limited (Filed With SEC on February 25, 2022)
- Common Stock Purchase Agreement, dated December 20, 2021, by and between the Company and RTW Innovation Master Fund, Ltd (Filed With SEC on February 25, 2022)
- Common Stock Purchase Agreement, dated December 20, 2021, by and between the Company and RTW Master Fund, Ltd (Filed With SEC on February 25, 2022)
- Form of Common Stock Purchase Agreement, dated July 14, 2020 (Filed With SEC on November 6, 2020)
- CYTOKINETICS, INCORPORATED COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on March 6, 2017)
- CYTOKINETICS, INCORPORATED Shares of Common Stock (par value$0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on September 4, 2015)
- CYTOKINETICS, INCORPORATED 2015 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:FEBRUARY 3, 2015 APPROVED BY THE STOCKHOLDERS:MAY 20, 2015 EFFECTIVE DATE: NOVEMBER... (Filed With SEC on August 5, 2015)
- CYTOKINETICS, INCORPORATED COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on December 23, 2014)
- CYTOKINETICS, INCORPORATED COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on June 12, 2013)
- CYTOKINETICS, INCORPORATED 2004 EMPLOYEE STOCK PURCHASE PLAN (As amended by the Board of Directors on March 15, 2006 and approved by the Stockholders May 25, 2006, asamended by... (Filed With SEC on March 15, 2013)
- CYTOKINETICS, INCORPORATED CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES B CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE... (Filed With SEC on June 20, 2012)
- CYTOKINETICS, INCORPORATED CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES A CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE... (Filed With SEC on April 18, 2011)
- AMENDMENT NO. 1 TO COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on October 26, 2010)
- 7,106,600 Shares of Common Stock and Warrants to Purchase up to 3,553,300 Shares of Common Stock CYTOKINETICS, INCORPORATED PLACEMENT AGENT AGREEMENT (Filed With SEC on May 19, 2009)
